Page last updated: 2024-10-22

aminoglutethimide and Adenohypophyseal Hyposecretion

aminoglutethimide has been researched along with Adenohypophyseal Hyposecretion in 3 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schramm, J1
Wüster, C1
Pan, CY1
Luo, GC1
Li, JY1
Wang, YZ1
Lu, SZ1
Ma, SQ1
Guo, AY1
Müller, J1

Other Studies

3 other studies available for aminoglutethimide and Adenohypophyseal Hyposecretion

ArticleYear
[Inhibited depressive syndrome in a patient with Cushing disease and anterior hypophysial insufficiency].
    Der Nervenarzt, 1991, Volume: 62, Issue:3

    Topics: Aminoglutethimide; Cushing Syndrome; Depressive Disorder; Empty Sella Syndrome; Female; Humans; Hydr

1991
Effects of aminoglutethimide on hypothalamic-pituitary-adrenal functions.
    Chinese medical journal, 1989, Volume: 102, Issue:11

    Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aminoglutethimide; Child; Cushing Syndrome; Female;

1989
Regulation of aldosterone biosynthesis.
    Monographs on endocrinology, 1971, Volume: 5

    Topics: Adrenal Cortex Hormones; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Aminoglutethimide

1971